Overview
Richeng Jiang practices in Tianjin, China. Jiang is rated as an Advanced expert by MediFind in the treatment of Squamous Cell Lung Carcinoma. Their top areas of expertise are Squamous Cell Lung Carcinoma, Lung Cancer, Lung Adenocarcinoma, and Non-Small Cell Lung Cancer (NSCLC).
Their clinical research consists of co-authoring 39 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Squamous Cell Lung Carcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerJiang isAdvanced. Learn about Lung Cancer.
- Squamous Cell Lung Carcinoma
- Experienced
- EGFR Positive Lung CancerJiang isExperienced. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaJiang isExperienced. Learn about Lung Adenocarcinoma.
- Multiple Endocrine NeoplasiaJiang isExperienced. Learn about Multiple Endocrine Neoplasia.
- Multiple Endocrine Neoplasia Type 2
- Non-Small Cell Lung Cancer (NSCLC)
- Salivary Gland TumorsJiang isExperienced. Learn about Salivary Gland Tumors.